Orbital myositis secondary to statin therapy

dc.contributor.authorBahrami, B.
dc.contributor.authorRajak, S.
dc.contributor.authorSelva, D.
dc.date.issued2015
dc.description.statementofresponsibilityBobak Bahrami, Bobak Bahrami, Dinesh Selva
dc.identifier.citationMedical Journal of Australia, 2015; 203(9):365-365
dc.identifier.doi10.5694/mja15.00503
dc.identifier.issn0025-729X
dc.identifier.issn1326-5377
dc.identifier.orcidBahrami, B. [0000-0003-1057-5142]
dc.identifier.orcidSelva, D. [0000-0002-2169-5417]
dc.identifier.urihttp://hdl.handle.net/2440/98111
dc.language.isoen
dc.publisherAustralasian Medical Publishing Company Ltd
dc.rights© 2015 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved.
dc.source.urihttps://doi.org/10.5694/mja15.00503
dc.subjectHumans
dc.subjectHypercholesterolemia
dc.subjectSimvastatin
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subjectMiddle Aged
dc.subjectMale
dc.subjectOrbital Myositis
dc.titleOrbital myositis secondary to statin therapy
dc.typeJournal article
pubs.publication-statusPublished

Files